Literature DB >> 25862810

MicroRNAs as the fine-tuners of Src oncogenic signalling.

Chitose Oneyama1, Masato Okada2.   

Abstract

The cellular Src (c-Src) tyrosine kinase is upregulated and believed to play a pivotal role in various human cancers. However, the molecular mechanism underlying c-Src-mediated tumour progression remains elusive. Recent studies have revealed that several microRNAs (miRNAs) function as tumour suppressors by regulating the malignant expression of signalling molecules. Aberrant expression of miRNAs is frequently observed in human cancers and should be exploited to seek related molecular targets. In this review, we focus on miRNAs found to be involved in Src signalling in various cancers. We summarize recent findings on Src-related miRNAs, their target genes, mechanisms behind their interplay and their implications for cancer therapeutics.
© The Authors 2015. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.

Entities:  

Keywords:  Src; cancer signalling; mTOR; microRNA; proto-oncogene

Mesh:

Substances:

Year:  2015        PMID: 25862810     DOI: 10.1093/jb/mvv036

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

1.  Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer.

Authors:  Jun Hyoung Park; Sajna Vithayathil; Santosh Kumar; Pi-Lin Sung; Lacey Elizabeth Dobrolecki; Vasanta Putluri; Vadiraja B Bhat; Salil Kumar Bhowmik; Vineet Gupta; Kavisha Arora; Danli Wu; Efrosini Tsouko; Yiqun Zhang; Suman Maity; Taraka R Donti; Brett H Graham; Daniel E Frigo; Cristian Coarfa; Patricia Yotnda; Nagireddy Putluri; Arun Sreekumar; Michael T Lewis; Chad J Creighton; Lee-Jun C Wong; Benny Abraham Kaipparettu
Journal:  Cell Rep       Date:  2016-02-25       Impact factor: 9.423

Review 2.  Resistance to Cell Death and Its Modulation in Cancer Stem Cells.

Authors:  Ahmad R Safa
Journal:  Crit Rev Oncog       Date:  2016

Review 3.  The roles of microRNAs related with progression and metastasis in human cancers.

Authors:  Hai-Ting Liu; Peng Gao
Journal:  Tumour Biol       Date:  2016-10-06

4.  microRNAs calibrate T cell responses by regulating mTOR.

Authors:  Matthias Merkenschlager; Antoine Marcais
Journal:  Oncotarget       Date:  2015-10-27

5.  The full recovery of mice (Mus Musculus C57BL/6 strain) from virus-induced sarcoma after treatment with a complex of DDMC delivery system and sncRNAs.

Authors:  Oxana V Klimenko; Alexey Sidorov
Journal:  Noncoding RNA Res       Date:  2019-03-30

6.  Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma.

Authors:  Saurabh Agarwal; Rajib Ghosh; Zaowen Chen; Anna Lakoma; Preethi H Gunaratne; Eugene S Kim; Jason M Shohet
Journal:  Oncotarget       Date:  2016-04-26

7.  Differential microRNA expression is associated with androgen receptor expression in breast cancer.

Authors:  Yaqin Shi; Fang Yang; Zijia Sun; Wenwen Zhang; Jun Gu; Xiaoxiang Guan
Journal:  Mol Med Rep       Date:  2016-12-09       Impact factor: 2.952

8.  c-Src promotes tumor progression through downregulation of microRNA-129-1-3p.

Authors:  Daisuke Okuzaki; Tomoe Yamauchi; Fumie Mitani; Mamiko Miyata; Yuichi Ninomiya; Risayo Watanabe; Hiroki Akamatsu; Chitose Oneyama
Journal:  Cancer Sci       Date:  2020-01-17       Impact factor: 6.716

9.  The Differential DNA Hypermethylation Patterns of microRNA-137 and microRNA-342 Locus in Early Colorectal Lesions and Tumours.

Authors:  Elham Kashani; Mahrooyeh Hadizadeh; Vahid Chaleshi; Reza Mirfakhraie; Chris Young; Sanaz Savabkar; Shiva Irani; Hamid Asadzadeh Aghdaei; Maziar Ashrafian Bonab
Journal:  Biomolecules       Date:  2019-09-21

10.  Use of QSAR Global Models and Molecular Docking for Developing New Inhibitors of c-src Tyrosine Kinase.

Authors:  Robert Ancuceanu; Bogdan Tamba; Cristina Silvia Stoicescu; Mihaela Dinu
Journal:  Int J Mol Sci       Date:  2019-12-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.